Soc. Generale Call 44 OMV 20.12.2.../ DE000SY1EB74 /
8/6/2024 9:13:17 AM | Chg.+0.007 | Bid11:05:53 AM | Ask11:05:53 AM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
0.053EUR | +15.22% | 0.047 Bid Size: 45,000 |
0.057 Ask Size: 45,000 |
OMV AG | 44.00 EUR | 12/20/2024 | Call |
GlobeNewswire
3/26
Intravacc announces positive data of first in human intranasal OMV based vaccine for SARS-CoV-2
GlobeNewswire
1/16
Intravacc Awarded US$ 633K CARB-X Funding to Develop a Vaccine that Prevents Gonorrhea Infections
GlobeNewswire
9/14/2023
Intravacc Announces Review Publication of OMV-based Intranasal Vaccines for Disease Prevention
euro adhoc
10/13/2021
EANS-Adhoc: OMV Aktiengesellschaft / OMV announces redemption of the NC6 Hybrid Notes 2015 EAE
GlobeNewswire
12/4/2018
CGG and OMV: Continue Cooperation with Multi-Year Extension of Dedicated Center
GlobeNewswire
12/4/2018
CGG and OMV: Continue Cooperation with Multi-Year Extension of Dedicated Center